Tocilizumab is Formulary-Restricted at Legacy Health. Approved for use when indicated for cytokine release syndrome (CRS).
For patients with COVID-19: Restricted to Infectious Disease approval 8am-5pm. ID consult team will assess the patient for appropriate inclusion/exclusion criteria.
Inclusion Criteria
Laboratory confirmed COVID-19
Age ≥ 18 years old
Receiving concomitant corticosteroid therapy (at least dexamethasone 6mg daily or equivalent)
Tocilizumab is Formulary-Restricted at Legacy Health. Approved for use when indicated for cytokine release syndrome (CRS).
For patients with COVID-19: Restricted to Infectious Disease approval 8am-5pm. ID consult team will assess the patient for appropriate inclusion/exclusion criteria.
Inclusion Criteria
Exclusion Criteria